Super-Specialist CROs: Commercializing Pharma R&D Expertise
Executive Summary
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
You may also be interested in...
Patheon Tightens The Supply Chain To Transform Pharma Outsource Manufacturing
Fueled by a series of strategic acquisitions, Patheon hopes to become the biopharma industry’s first single-source, end-to-end manufacturing service provider.
IO Driving Surge In Number, Complexity Of Cancer Trials
Nearly half of all late-stage cancer trials that started in 2015 had an antibody component, and 2016 brings the first full survival data from pivotal multi-checkpoint antibody trials. We document the immuno-oncology surge in data.
Sanofi Makes Good On Outsourcing Promise In Deal With Covance
Sanofi-Aventis’ multi-layered 10-year deal with the contract research organization Covance, announced September 30, 2010, is yet another sign of the pressure within Big Pharma to cut R&D costs even as it searches for new sources of innovation.